Bliss GVS Pharma fundamental analysis
BLISSGVS
217.82
0.38 (-0.17%)Last updated on 13 Feb, 2026 | 15:57 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Bliss GVS Pharma Fundamentals
P/E Ratio
21.14
P/B Ratio
1.99
Div. Yield
0.23
Sector P/E
64.85
Sector P/B
1.43
Sec. Div. Yield
0.57
Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 21.14, compared to the sector average of 64.85. Its P/B Ratio stands at 1.99, while the sector’s is 1.43. In terms of returns, the stock offers a Dividend Yield of 0.23%, which is than the sector’s 0.57%.
Bliss GVS Pharma Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Average
On its scorecard, Bliss GVS Pharma reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
